Molecular Diagnostics market is mainly segmented on the basis of type of Technology, Products and Services, End Users, Applications and by Region/Country. On the basis of Technology, the market is segmented into Polymerase Chain Reaction (PCR), Isothermal Nucleic Acid Amplification Technology (INAAT), Hybridization (In Situ Hybridization and FISH), DNA Sequencing and NGS, Microarray and Others. The market is further segmented into Products and Services of molecular diagnostics such as, Reagents & Kits, Instruments and Software & Services. The market by End Users is segmented as Hospitals, Diagnostics Laboratories, Academic Research Institutes and Others which include blood banks etc. The molecular diagnostics market finds its application in Infectious Disease, Oncology, Pharmacogenomics, Microbiology, Genetic Disease Screening, Human Leukocyte Antigen Typing and Blood Screening.
The report includes market size estimation for regions such as Americas, Europe, Asia-Pacific and Middle East & Africa. Key companies which lead the Molecular Diagnostics market are profiled in the report such as Abbott Laboratories, Qiagen N.V. , Roche Diagnostics, Hologic, Inc. , Grifols , Siemens Healthcare , Becton, Dickinson and Company , Beckman Coulter Inc. (subsidiary of Danaher Corporation), Biomérieux SA and Cepheid Inc. The company profiles includes business overview of the company, financial highlights, products and recent developments related to Molecular Diagnostics market.